Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

20.88
Delayed Data
As of 3:59pm ET
 +0.24 / +1.16%
Today’s Change
20.51
Today|||52-Week Range
43.63
-51.19%
Year-to-Date

Today’s Trading

Previous close20.64
Today’s open20.75
Day’s range20.51 - 21.15
Volume924,257
Average volume (3 months)573,020
Market cap$952.3M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-59.26%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratioNM
Price/Sales3.79
Price/Book1.47

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S+0.63+3.09%
SGYPSynergy Pharmaceutic...+0.20+3.77%
LCILannett Company Inc-0.22-0.82%
RGENRepligen Corp+0.65+2.20%
Data as of 4:03pm ET, 09/30/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.10
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

Search for Jobs